We are live on ! Find out more
IIM

Illumine Investment Management Portfolio holdings

AUM $154M
1-Year Est. Return 52.22%
This Fund
S&P 500
This Quarter Est. Return
-1.31%
1 Year Est. Return
+52.22%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$122M
AUM Growth
+$592K
Cap. Flow
+$5.4M
Cap. Flow %
4.42%
Top 10 Hldgs %
31.72%
Holding
93
New
2
Increased
54
Reduced
16
Closed
3

Sector Composition

Rank Sector Weight
1 Technology 23.09%
2 Healthcare 15.98%
3 Financials 12.31%
4 Industrials 8.73%
5 Consumer Discretionary 5.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.57T
$5.25M 4.3%
23,625
+36
+0.2% +$8.34K
JPST icon
2
JPMorgan Ultra-Short Income ETF
JPST
$40.3B
$4.17M 3.41%
82,320
+9,473
+13% +$479K
COST icon
3
Costco
COST
$420B
$4.05M 3.32%
4,282
-56
-1% -$54.6K
ISRG icon
4
Intuitive Surgical
ISRG
$134B
$3.74M 3.06%
7,553
-34
-0.4% -$18.8K
HYBI
5
NEOS Enhanced Income Credit Select ETF
HYBI
$221M
$3.71M 3.04%
74,412
+3,313
+5% +$169K
WRB icon
6
W.R. Berkley
WRB
$26.6B
$3.68M 3.01%
51,697
+197
+0.4% +$12.1K
DASH icon
7
DoorDash
DASH
$93.7B
$3.67M 3%
20,059
-348
-2% -$65.4K
SEIX icon
8
Virtus SEIX Senior Loan ETF
SEIX
$252M
$3.64M 2.98%
154,079
+13,004
+9% +$310K
TMUS icon
9
T-Mobile US
TMUS
$190B
$3.5M 2.86%
13,107
-371
-3% -$91.5K
GOF icon
10
Guggenheim Strategic Opportunities Fund
GOF
$2.26B
$3.33M 2.73%
213,929
+40,462
+23% +$629K
KMLM icon
11
KFA Mount Lucas Managed Futures Index Strategy ETF
KMLM
$405M
$2.98M 2.44%
109,123
+20,453
+23% +$561K
IBKR icon
12
Interactive Brokers
IBKR
$39.8B
$2.95M 2.41%
71,212
-3,128
-4% -$155K
INTU icon
13
Intuit
INTU
$89B
$2.91M 2.38%
4,732
+119
+3% +$71.5K
VRTX icon
14
Vertex Pharmaceuticals
VRTX
$126B
$2.84M 2.32%
5,854
+78
+1% +$36.3K
UTHR icon
15
United Therapeutics
UTHR
$23.1B
$2.65M 2.17%
8,604
+58
+0.7% +$19.9K
AMD icon
16
Advanced Micro Devices
AMD
$789B
$2.53M 2.07%
24,644
+1,031
+4% +$115K
TW icon
17
Tradeweb Markets
TW
$21.6B
$2.52M 2.07%
16,992
+157
+0.9% +$20.9K
TLT icon
18
iShares 20+ Year Treasury Bond ETF
TLT
$41.7B
$2.25M 1.84%
24,721
+3,780
+18% +$336K
PGR icon
19
Progressive
PGR
$125B
$2.2M 1.8%
7,758
+310
+4% +$81.1K
ANET icon
20
Arista Networks
ANET
$238B
$2.17M 1.78%
28,051
-404
-1% -$41K
REGN icon
21
Regeneron Pharmaceuticals
REGN
$80.8B
$1.97M 1.61%
3,106
+116
+4% +$79.8K
DRS icon
22
Leonardo DRS
DRS
$12B
$1.87M 1.53%
56,982
+1,773
+3% +$58.5K
GBTC icon
23
Grayscale Bitcoin Trust
GBTC
$9.76B
$1.86M 1.53%
28,599
-1,773
-6% -$131K
XYL icon
24
Xylem
XYL
$28.1B
$1.86M 1.52%
15,552
+304
+2% +$37.7K
ZM icon
25
Zoom
ZM
$30.6B
$1.81M 1.48%
24,511
+64
+0.3% +$5.1K

Similar funds

Illumine Investment Management's Q1 2025 Portfolio in Review

As of Q1 2025, Illumine Investment Management held 93 positions worth $122M, up 0.49% from $122M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Illumine Investment Management deployed $5.4M of net new capital in Q1 2025, opening 2 new positions and adding to 54 existing holdings. Its largest new stake was Axcelis: 9,731 shares worth $483K.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Corcept Therapeutics, an estimated $491K trimmed.

  • Illumine Investment Management's largest Q1 2025 buy was Axcelis: 9,731 shares worth $483K.
  • Illumine Investment Management added most to Guggenheim Strategic Opportunities Fund in Q1 2025, an estimated $629K increase.
  • Illumine Investment Management's biggest Q1 2025 reduction was Corcept Therapeutics, cutting an estimated $491K.
  • Illumine Investment Management fully exited Novo Nordisk in Q1 2025, selling an estimated $242K.
  • Illumine Investment Management's ten largest holdings make up 32% of its $122M portfolio in Q1 2025.
  • Illumine Investment Management opened 2 new positions and closed 3 in Q1 2025.
  • Illumine Investment Management's portfolio value rose 0.49% quarter-over-quarter to $122M.

Based on Illumine Investment Management's 13F filing for Q1 2025, filed 22 Apr 2025.